• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years.波兰心血管疾病的经济成本：2015 - 2017年估算
Front Pharmacol. 2020 Sep 8;11:1231. doi: 10.3389/fphar.2020.01231. eCollection 2020.
2
The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years.波兰 2014-2016 年癫痫的直接和间接成本估算。
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):353-362. doi: 10.1080/14737167.2019.1533817. Epub 2018 Oct 24.
3
Indirect costs of diabetes and its impact on the public finance: the case of Poland.糖尿病的间接成本及其对公共财政的影响：以波兰为例。
Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):93-105. doi: 10.1080/14737167.2017.1366857. Epub 2017 Aug 31.
4
Economic and social cost of epilepsy in Poland: 5-year analysis.波兰癫痫的经济和社会成本：5 年分析。
Eur J Health Econ. 2021 Apr;22(3):485-497. doi: 10.1007/s10198-021-01269-1. Epub 2021 Feb 13.
5
The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.波兰乳腺癌的直接和间接成本：2017-2019 年的估计。
Int J Environ Res Public Health. 2022 Dec 7;19(24):16384. doi: 10.3390/ijerph192416384.
6
The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.COVID-19 大流行对波兰精神疾病和行为障碍间接成本的影响。
Front Public Health. 2023 Sep 18;11:1207389. doi: 10.3389/fpubh.2023.1207389. eCollection 2023.
7
[The costs of asthma in Poland in 2012].[2012年波兰哮喘病的成本]
Pol Merkur Lekarski. 2015 Aug;39(230):91-5.
8
[Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].[病毒性呼吸道感染和肺炎疾病对波兰老年人口的健康经济影响]
Pol Merkur Lekarski. 2010 Jul;29(169):37-40.
9
Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.2010-2014 年波兰归因于乳腺癌的生产力损失和公共财政负担。
BMC Cancer. 2017 Oct 10;17(1):676. doi: 10.1186/s12885-017-3669-7.
10
Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.与氯吡格雷相比，替格瑞洛用于急性冠状动脉综合征二级预防的直接医疗成本及成本效益：基于PLATO试验结果，从波兰公共支付方角度进行的经济学评估
Kardiol Pol. 2014;72(9):823-30. doi: 10.5603/KP.a2014.0106. Epub 2014 May 20.

引用本文的文献

1
Combination of robot-assisted glove and mirror therapy improves upper limb motor function in subacute stroke patients: a randomized controlled pilot study.机器人辅助手套与镜像疗法相结合改善亚急性中风患者上肢运动功能：一项随机对照试验性研究。
Front Neurol. 2025 Jun 16;16:1602896. doi: 10.3389/fneur.2025.1602896. eCollection 2025.
2
Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis.他汀类药物、依折麦布和贝特类药物单药治疗或联合治疗高脂血症的疗效和安全性：一项系统评价和网状Meta分析。
Eur J Med Res. 2025 Jun 23;30(1):509. doi: 10.1186/s40001-025-02805-y.
3
Association between cardiometabolic index and postmenopausal stress urinary incontinence: a cross-sectional study from NHANES 2013 to 2018.心脏代谢指数与绝经后压力性尿失禁之间的关联：一项基于2013年至2018年美国国家健康与营养检查调查（NHANES）的横断面研究。
Lipids Health Dis. 2025 May 21;24(1):184. doi: 10.1186/s12944-025-02601-x.
4
Economic burden of cardiovascular diseases among elderly patients in Iran: a case from a developing country.伊朗老年人心血管疾病的经济负担：来自发展中国家的案例。
BMC Health Serv Res. 2024 Nov 6;24(1):1355. doi: 10.1186/s12913-024-11808-0.
5
Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years.中国西南贫困农村地区国家基本药物政策对药品供应、价格和使用的短期和长期影响：8 年的中断时间序列分析。
Front Public Health. 2024 Aug 29;12:1355239. doi: 10.3389/fpubh.2024.1355239. eCollection 2024.
6
The Role of Carotid-Femoral Pulse Wave Velocity in a Metabolic Syndrome Patient with Sudden Cardiac Arrest: A Case Report.颈动脉-股动脉脉搏波速度在一名心脏骤停代谢综合征患者中的作用：病例报告
Healthcare (Basel). 2024 Feb 18;12(4):491. doi: 10.3390/healthcare12040491.
7
Productivity losses from short-term work absence due to neoplasms in Poland.波兰因肿瘤导致的短期工作缺勤的生产力损失。
Sci Rep. 2024 Feb 8;14(1):3289. doi: 10.1038/s41598-024-53878-4.
8
Open versus Transcutaneous (Ultrasound-Guided and Based on Anatomic Landmarks) Tunneled Venous Access to the Right Internal Jugular Vein in Children: A Prospective Single-Center Study.儿童经皮（超声引导和基于解剖标志）与开放隧道式右颈内静脉静脉通路：一项前瞻性单中心研究
Diseases. 2023 Nov 30;11(4):174. doi: 10.3390/diseases11040174.
9
The Effect of Craniosacral Therapy on Blood Levels of Stress Hormones in Male Firefighter Cadets: A Randomized Clinical Trial.颅骶疗法对男性消防员学员应激激素血液水平的影响：一项随机临床试验。
Behav Sci (Basel). 2023 Nov 8;13(11):914. doi: 10.3390/bs13110914.
10
Exploring Patient Beliefs and Medication Adherence in the Mediterranean Context: A Cross-Sectional Study in Patients with Cardiovascular Diseases and Cardiometabolic Disorders in Greece-The IACT-Study.探索地中海地区患者的信念与药物依从性：希腊心血管疾病和心脏代谢紊乱患者的横断面研究——IACT研究
Life (Basel). 2023 Sep 7;13(9):1880. doi: 10.3390/life13091880.

本文引用的文献

1
Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.波兰与其他中东欧国家 1990-2017 年疾病负担变化的比较：2017 年全球疾病负担研究的系统分析。
PLoS One. 2020 Mar 2;15(3):e0226766. doi: 10.1371/journal.pone.0226766. eCollection 2020.
2
Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK).二尖瓣手术中房颤外科消融术后的生存率：来自波兰心脏手术程序国家登记处（KROK）的分析。
J Thorac Cardiovasc Surg. 2019 Mar;157(3):1007-1018.e4. doi: 10.1016/j.jtcvs.2018.07.099. Epub 2018 Sep 8.
3
A systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countries.非传染性疾病与中低收入国家社会经济地位关系的系统评价。
J Glob Health. 2018 Dec;8(2):020409. doi: 10.7189/jogh.08.020409.
4
Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil.巴西过去五年心血管疾病的经济影响分析。
Arq Bras Cardiol. 2017 Jul;109(1):39-46. doi: 10.5935/abc.20170068. Epub 2017 Jun 1.
5
Cath lab costs in patients undergoing percutaneous coronary angioplasty - detailed analysis of consecutive procedures.接受经皮冠状动脉介入治疗患者的导管室成本——连续手术的详细分析
Kardiol Pol. 2017;75(9):914-921. doi: 10.5603/KP.a2017.0098. Epub 2017 May 25.
6
Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.与心血管事件及相关临床程序相关的生产力损失和间接成本。
BMC Health Serv Res. 2015 Jun 25;15:245. doi: 10.1186/s12913-015-0925-x.
7
Analysis of direct costs of hypertension treatment among adolescents in Poland.波兰青少年高血压治疗的直接成本分析。
Acta Pol Pharm. 2014 Jan-Feb;71(1):197-203.
8
Costs of cardiac care likely to increase, despite advances in prevention, care.尽管在预防和治疗方面取得了进展，但心脏护理的成本可能会增加。
JAMA. 2013 Nov 20;310(19):2029. doi: 10.1001/jama.2013.282805.
9
Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.心血管疾病一级预防计划在基层医疗保健环境中的成本效益。EUROACTION 项目波兰部分的结果。
Kardiol Pol. 2013;71(7):702-11. doi: 10.5603/KP.2013.0157.
10
The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.从公共支付者角度看波兰心力衰竭的成本。波兰方案评估了在不同护理水平的随机选择的门诊诊所和医院的心力衰竭患者的诊断程序、治疗和费用：POLKARD。
Kardiol Pol. 2013;71(3):224-32. doi: 10.5603/KP.2013.0032.

波兰心血管疾病的经济成本：2015 - 2017年估算

Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years.

作者信息

Mela Aneta, Rdzanek Elżbieta, Poniatowski Łukasz A, Jaroszyński Janusz, Furtak-Niczyporuk Marzena, Gałązka-Sobotka Małgorzata, Olejniczak Dominik, Niewada Maciej, Staniszewska Anna

机构信息

Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Warsaw, Poland.

Department of Neurosurgery, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.

出版信息

Front Pharmacol. 2020 Sep 8;11:1231. doi: 10.3389/fphar.2020.01231. eCollection 2020.

DOI:10.3389/fphar.2020.01231
PMID:33013357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7506040/
Abstract

BACKGROUND

Cardiovascular diseases are associated with growing public and private expenditure on healthcare regardless geographic region. Therefore, it is necessary to accurately estimate the overall societal costs-both direct and indirect expenses from the perspective of patients, caregivers and employers.

RESEARCH DESIGN

The aim of this paper is to determine the direct and indirect costs related to cardiovascular diseases in Poland from 2015 to 2017. All costs are estimated based on data available in the public domain and obtained from the major Polish institutions. Indirect costs were calculated using a modified human capital approach.

RESULTS

The financial burden of cardiovascular diseases in Poland is significant. This study revealed that total costs (direct and indirect) of cardiovascular diseases, for 2015-2017, range from 34.9 bn PLN (8.2 bn EUR) to over 40.9 bn PLN (9.6 bn EUR). Total direct cost and indirect costs were approximately 6.1 bn PLN (1.4 bn EUR) (16%) and 31.3 bn PLN (7.3 bn EUR) (84%), respectively.

CONCLUSION

Collectively, the estimated direct and indirect cost of cardiovascular diseases provide a useful input for economic impact assessments of public health programs and health technology analyses.

摘要

背景

无论地理区域如何，心血管疾病都与公共和私人医疗保健支出的增长相关。因此，有必要从患者、护理人员和雇主的角度准确估计总体社会成本，包括直接和间接费用。

研究设计

本文旨在确定2015年至2017年波兰与心血管疾病相关的直接和间接成本。所有成本均根据公共领域可用的数据并从波兰主要机构获取的数据进行估算。间接成本采用改良的人力资本方法计算。

结果

波兰心血管疾病的经济负担很重。该研究表明，2015年至2017年心血管疾病的总成本（直接和间接）从349亿波兰兹罗提（82亿欧元）到超过409亿波兰兹罗提（96亿欧元）不等。直接成本和间接成本总计分别约为61亿波兰兹罗提（14亿欧元）（16%）和313亿波兰兹罗提（73亿欧元）（84%）。

结论

总体而言，心血管疾病的直接和间接成本估计为公共卫生项目的经济影响评估和卫生技术分析提供了有用的参考。